A detailed history of Lederer & Associates Investment Counsel transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lederer & Associates Investment Counsel holds 8,729 shares of MRK stock, worth $1.11 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
8,729
Previous 9,859 11.46%
Holding current value
$1.11 Million
Previous $1.08 Million 7.16%
% of portfolio
0.8%
Previous 0.8%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$113.24 - $131.95 $127,961 - $149,103
-1,130 Reduced 11.46%
8,729 $1.15 Million
Q4 2023

Jan 19, 2024

SELL
$100.18 - $109.02 $13,824 - $15,044
-138 Reduced 1.38%
9,859 $1.08 Million
Q3 2023

Oct 23, 2023

BUY
$102.95 - $114.33 $5,971 - $6,631
58 Added 0.58%
9,997 $1.03 Million
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $30,953 - $33,738
285 Added 2.95%
9,939 $1.15 Million
Q1 2023

Apr 17, 2023

BUY
$102.94 - $114.86 $237,070 - $264,522
2,303 Added 31.33%
9,654 $1.03 Million
Q4 2022

Jan 12, 2023

SELL
$87.44 - $112.11 $454,862 - $583,196
-5,202 Reduced 41.44%
7,351 $816,000
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $23,921 - $26,873
-283 Reduced 2.2%
12,553 $1.08 Million
Q2 2022

Aug 09, 2022

BUY
$83.49 - $94.64 $2,838 - $3,217
34 Added 0.27%
12,836 $1.17 Million
Q1 2022

May 24, 2022

BUY
$73.51 - $82.4 $4,778 - $5,356
65 Added 0.51%
12,802 $1.05 Million
Q4 2021

Jan 24, 2022

BUY
$72.28 - $90.54 $154,173 - $193,121
2,133 Added 20.12%
12,737 $976,000
Q3 2021

Oct 22, 2021

BUY
$71.68 - $78.83 $251,596 - $276,693
3,510 Added 49.48%
10,604 $796,000
Q2 2021

Jul 23, 2021

BUY
$70.31 - $77.77 $15,116 - $16,720
215 Added 3.13%
7,094 $552,000
Q1 2021

Apr 19, 2021

BUY
$68.86 - $81.11 $68,584 - $80,785
996 Added 16.93%
6,879 $506,000
Q4 2020

Jan 25, 2021

BUY
$71.77 - $79.65 $87,846 - $97,491
1,224 Added 26.27%
5,883 $481,000
Q3 2020

Jan 13, 2021

BUY
$73.18 - $82.95 $28,467 - $32,267
389 Added 9.11%
4,659 $386,000
Q2 2020

Jul 14, 2020

SELL
$70.42 - $80.13 $8,450 - $9,615
-120 Reduced 2.73%
4,270 $330,000
Q1 2020

Apr 20, 2020

BUY
$63.36 - $87.82 $80,784 - $111,970
1,275 Added 40.93%
4,390 $338,000
Q4 2019

Feb 07, 2020

SELL
$77.58 - $87.54 $4,654 - $5,252
-60 Reduced 1.89%
3,115 $283,000
Q3 2019

Oct 07, 2019

SELL
$76.08 - $82.93 $7,988 - $8,707
-105 Reduced 3.2%
3,175 $267,000
Q2 2019

Jul 19, 2019

SELL
$69.84 - $81.59 $43,999 - $51,401
-630 Reduced 16.11%
3,280 $275,000
Q1 2019

Apr 12, 2019

SELL
$69.58 - $79.36 $21,221 - $24,204
-305 Reduced 7.24%
3,910 $325,000
Q4 2018

Jan 25, 2019

SELL
$65.24 - $75.71 $29,031 - $33,690
-445 Reduced 9.55%
4,215 $322,000
Q3 2018

Oct 22, 2018

SELL
$57.69 - $67.84 $3,461 - $4,070
-60 Reduced 1.27%
4,660 $331,000
Q2 2018

Jul 27, 2018

BUY
$50.83 - $59.72 $4,574 - $5,374
90 Added 1.94%
4,720 $287,000
Q1 2018

Apr 09, 2018

BUY
$50.96 - $59.23 $19,874 - $23,099
390 Added 9.2%
4,630 $252,000
Q3 2017

Oct 13, 2017

BUY
$58.67 - $63.13 $248,760 - $267,671
4,240
4,240 $271,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $322B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Lederer & Associates Investment Counsel Portfolio

Follow Lederer & Associates Investment Counsel and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lederer & Associates Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Lederer & Associates Investment Counsel with notifications on news.